Octans Pharma (Opc) Private Limited
Founded in 2022 and headquartered in Maharashtra, India.
2022 | Thane, Maharashtra (India) | Active
Octans Pharma (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Octans Pharma (Opc)
Octans Pharma (Opc) Private Limited (OPOPL) is a Company incorporated in India on 17 February 2022 (Three years and one month 12 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepika Chavan serves as a director at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24302MH2022OPC377035
- Company No.
377035
- Incorporation Date
17 Feb 2022
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Food And Beverages
Textile
Who are the key members and board of directors at Octans Pharma (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepika Chavan  | Director | 17-Feb-2022 | Current |
Financial Performance of Octans Pharma (Opc).
Enhance accessibility to Octans Pharma (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Octans Pharma (Opc)?
Unlock access to Octans Pharma (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Dorcia Biotech Private Limited
Deepika Chavan is a mutual person
- Rerum Laboratories Private Limited
Deepika Chavan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Octans Pharma (Opc)?
Octans Pharma (Opc) has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Octans Pharma (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Octans Pharma (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Octans Pharma (Opc)
Recent activity within the organization
- Balance Sheet
Octans Pharma (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Annual General Meeting
Octans Pharma (Opc) Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.
- Director Appointment
Deepika Vikas Chavan was appointed as a Director was appointed as a Director on 17 Feb 2022 & has been associated with this company since 3 years 1 month .
- Company Incorporation
Octans Pharma (Opc) Private Limited was registered on 17 Feb 2022 with Roc Mumbai & aged 3 years 1 month as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Octans Pharma (Opc) Private Limited?
Octans Pharma (Opc) Private Limited was incorporated on 17 Feb 2022.
What is authorized share capital and paid-up capital of Octans Pharma (Opc) Private Limited?
The authorized share capital of Octans Pharma (Opc) Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Octans Pharma (Opc) Private Limited?
Currently 1 director is associated with Octans Pharma (Opc) Private Limited.
- Deepika Vikas Chavan
What is the registered address of Octans Pharma (Opc) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Octans Pharma (Opc) Private Limited is Shop-12 Jainam Height Near Orage Nile More India, Nalasopara, Maharashtra, 401203.
What is the corporate identification number (CIN) and company number of Octans Pharma (Opc) Private Limited?
The corporate identification number (CIN) of Octans Pharma (Opc) Private Limited is U24302MH2022OPC377035 and the company number is 377035 as per Ministry of Corporate Affairs (MCA).
When was the last Balance Sheet of Octans Pharma (Opc) Private Limited filed with the ROC?
The most recent Balance Sheet for Octans Pharma (Opc) Private Limited was filed with the ROC on 31 Mar 2024.